LinKinVax
Paris
About LinKinVax
LinKinVax operates as a clinical-stage biotechnology company. LinKinVax is developing an innovative protein-based vaccine platform that can accelerate availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: linkinvax.com
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/linkinvax-20048 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.